Symposium | Nanomedicines: Enabling New Therapeutic Modalities

July 15, 2017 | Cambridge, MA, USA

Register for the EVENT in Cambridge, MA  OR  LIVESTREAM.

Nanomedicine symposium

Annual Symposium | Nanomedicines: Enabling New Therapeutic Modalities

Join us in Cambridge preceding the Controlled Release Society meeting for our Nanomedicines: Enabling New Therapeutic Modalities symposium, where we will host a panel of great speakers across industry and academia. Presentations will highlight recent advances in nanomedicine research and development from gene delivery and screening, to nanomedicine formulation and development for the clinic. We will learn how researchers are being enabled with new technology to create new therapeutics.

Cambridge symposium speakers from industry and academia.

Harvard, GSK, Moderna and Tel-Aviv University speakers for the symposium.

Complete List of Speakers

Patrick Baumhof – Vice President Formulation & Delivery, CureVac AG

Charles Bowerman – Formulation Scientist, Moderna Therapeutics

John Cooke – Professor, Cardiovascular Sciences, Houston Methodist & Weill Cornell Medical College
“RNA Nanotherapeutics for Cardiovascular Disease”

Derek O’Hagan – Head of Global Discovery Support and New Technologies, GSK Vaccines

Dan Peer – Professor, Department of Cell Research and Immunology, Tel-Aviv University
“To target or not to Target: Lessons from RNAi-based Targeted Lipid Nanoparticles”

Le An – Senior Scientist, Genentech

Frank Slack – Department of Pathology, Beth Isreal Deaconess Medical Centre, Harvard